Abstract
For newborns suspected having childhood interstitial lung disease (ChILD), the sequencing of genes encoding surfactant proteins is recommended. However, it is still difficult to interpret the clinical significance of those variants found. We report a full-term born female infant who presented with respiratory distress and failure to thrive at 2 months of age and both imaging and lung biopsy were consistent with ChILD. Her genetic test was initially reported as a variant of unknown significance in surfactant protein C (c.202G > T, p.V68F), which was modified later as likely pathogenic after reviewing a report of the same variant as causing ChILD. The infant was placed on noninvasive ventilation and treated with IV Methylprednisolone, Hydroxychloroquine, and Azithromycin but did not show significant clinical and radiological improvement underwent tracheostomy and is awaiting lung transplantation at 8 months of age. The challenges interpreting the genetic results are discussed.
This is a preview of subscription content, log in via an institution to check access.
References
Kuo CS, Young LR (2014) Interstitial lung disease in children. Curr Opin Pediatr 26(3):320–327. https://doi.org/10.1097/MOP.0000000000000094
Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG et al (2013) An official American thoracic society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 188(3):376–394. https://doi.org/10.1164/rccm.201305-0923ST
Willander H, Askarieh G, Landreh M, Westermark P, Nordling K, Keranen H et al (2012) High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci U S A 109(7):2325–2329. https://doi.org/10.1073/pnas.1114740109
Spagnolo P, Bush A (2016) Interstitial lung disease in children younger than 2 years. Pediatrics. https://doi.org/10.1542/peds.2015-2725
Wert SE, Whitsett JA, Nogee LM (2009) Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 12(4):253–274. https://doi.org/10.2350/09-01-0586.1
Hamvas A, Cole FS, Nogee LM (2007) Genetic disorders of surfactant proteins. Neonatology 91(4):311–317. https://doi.org/10.1159/000101347
Crossno PF, Polosukhin VV, Blackwell TS, Johnson JE, Markin C, Moore PE et al (2010) Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Chest 137(4):969–973. https://doi.org/10.1378/chest.09-0790
Hayasaka I, Cho K, Akimoto T, Ikeda M, Uzuki Y, Yamada M et al (2018) Genetic basis for childhood interstitial lung disease among Japanese infants and children. Pediatr Res 83(2):477–483. https://doi.org/10.1038/pr.2017.217
Somaschini M, Presi S, Ferrari M, Vergani B, Carrera P (2018) Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome. J Perinatol 38(4):337–344. https://doi.org/10.1038/s41372-017-0018-2
Park JS, Choi YJ, Kim YT, Park S, Chae JH, Park JD et al (2018) Pediatric case report on an interstitial lung disease with a novel mutation of SFTPC successfully treated with lung transplantation. J Korean Med Sci 33(22):e159. https://doi.org/10.3346/jkms.2018.33.e159
Litao MK, Hayes D Jr, Chiwane S, Nogee LM, Kurland G, Guglani L (2017) A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy. Pediatr Pulmonol 52(1):57–68. https://doi.org/10.1002/ppul.23493
Delestrain C, Simon S, Aissat A, Medina R, Decrouy X, Nattes E et al (2017) Deciphering the mechanism of Q145H SFTPC mutation unmasks a splicing defect and explains the severity of the phenotype. Eur J Hum Genet 25(6):779–782. https://doi.org/10.1038/ejhg.2017.36
Bullard JE, Nogee LM (2007) Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 62(2):176–179. https://doi.org/10.1203/PDR.0b013e3180a72588
Benden C, Edwards LB, Kucheryavaya AY, Christie JD, Dipchand AI, Dobbels F et al (2013) The registry of the international society for heart and lung transplantation: sixteenth official pediatric lung and heart-lung transplantation report–2013; focus theme: age. J Heart Lung Transplant 32(10):989–997. https://doi.org/10.1016/j.healun.2013.08.008
Liu F, Jin YL, Li HX, Chen Y, Wu B, Shi LZ et al (2020) Pediatric case report: successful bilateral lung transplantation performed to treat an 8-year-old girl with pulmonary interstitial fibrosis due to surfactant protein (SP)-C gene mutation. Chin Med J (Engl) 134(4):498–500. https://doi.org/10.1097/CM9.0000000000001053
Poterjoy BS, Vibert Y, Sola-Visner M, McGowan J, Visner G, Nogee LM (2010) Neonatal respiratory failure due to a novel mutation in the surfactant protein C gene. J Perinatol 30(2):151–153. https://doi.org/10.1038/jp.2009.97
Eldridge WB, Zhang Q, Faro A, Sweet SC, Eghtesady P, Hamvas A et al (2017) Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism. J Pediatr 184(157–64):e2. https://doi.org/10.1016/j.jpeds.2017.01.017
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Park, H., Bidiwala, A., Conrad, L.A. et al. Child Interstitial Lung Disease in an Infant with Surfactant Protein C Dysfunction due to c.202G>T Variant (p.V68F). Lung 200, 67–71 (2022). https://doi.org/10.1007/s00408-021-00501-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-021-00501-2